Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Edward Yeh to Humans

This is a "connection" page, showing publications Edward Yeh has written about Humans.

 
Connection Strength
  
 
 
1.320
  
  1. Chang HM, Yeh ETH. SUMO: From Bench to Bedside. Physiol Rev. 2020 10 01; 100(4):1599-1619.
    View in: PubMed
    Score: 0.031
  2. Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Semin Oncol. 2019 12; 46(6):397-402.
    View in: PubMed
    Score: 0.029
  3. Yang FM, Zuo Y, Zhou W, Xia C, Hahm B, Sullivan M, Cheng J, Chang HM, Yeh ET. sNASP inhibits TLR signaling to regulate immune response in sepsis. J Clin Invest. 2018 06 01; 128(6):2459-2472.
    View in: PubMed
    Score: 0.026
  4. Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular Complications of Cancer?Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1. J Am Coll Cardiol. 2017 Nov 14; 70(20):2536-2551.
    View in: PubMed
    Score: 0.025
  5. Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH. Cardiovascular Complications of Cancer?Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. J Am Coll Cardiol. 2017 Nov 14; 70(20):2552-2565.
    View in: PubMed
    Score: 0.025
  6. Yeh ETH, Chang HM. Cancer and Clot: Between a Rock and a Hard Place. J Am Coll Cardiol. 2017 08 22; 70(8):939-941.
    View in: PubMed
    Score: 0.025
  7. Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J, Yeh ET. SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 2017 Mar 14; 8(11):17651-17664.
    View in: PubMed
    Score: 0.024
  8. Abe J, Martin JF, Yeh ET. The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters". Circ Res. 2016 09 30; 119(8):896-9.
    View in: PubMed
    Score: 0.023
  9. Lenihan DJ, Stevens PL, Massey M, Plana JC, Araujo DM, Fanale MA, Fayad LE, Fisch MJ, Yeh ET. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. J Card Fail. 2016 Jun; 22(6):433-8.
    View in: PubMed
    Score: 0.023
  10. Huang C, Cheng J, Bawa-Khalfe T, Yao X, Chin YE, Yeh ETH. SUMOylated ORC2 Recruits a Histone Demethylase to Regulate Centromeric Histone Modification and Genomic Stability. Cell Rep. 2016 Apr 05; 15(1):147-157.
    View in: PubMed
    Score: 0.022
  11. Moudgil R, Yeh ET. Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond. Can J Cardiol. 2016 07; 32(7):863-870.e5.
    View in: PubMed
    Score: 0.022
  12. Ritho J, Arold ST, Yeh ET. A Critical SUMO1 Modification of LKB1 Regulates AMPK Activity during Energy Stress. Cell Rep. 2015 Aug 04; 12(5):734-42.
    View in: PubMed
    Score: 0.021
  13. Yeh ET, Vejpongsa P. Subclinical Cardiotoxicity Associated With?Cancer Therapy: Early Detection and Future Directions. J Am Coll Cardiol. 2015 Jun 16; 65(23):2523-5.
    View in: PubMed
    Score: 0.021
  14. Vejpongsa P, Yeh ET. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol. 2014 Sep 02; 64(9):938-45.
    View in: PubMed
    Score: 0.020
  15. Vejpongsa P, Yeh ET. Topoisomerase 2?: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity. Clin Pharmacol Ther. 2014 Jan; 95(1):45-52.
    View in: PubMed
    Score: 0.019
  16. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012 Nov; 18(11):1639-42.
    View in: PubMed
    Score: 0.018
  17. Bawa-Khalfe T, Lu LS, Zuo Y, Huang C, Dere R, Lin FM, Yeh ET. Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):17466-71.
    View in: PubMed
    Score: 0.018
  18. Yeh ET, Willerson JT. Heparin and bone marrow-derived cell therapy: friend or foe? Circ Res. 2012 Sep 14; 111(7):819-20.
    View in: PubMed
    Score: 0.018
  19. Schwartz RJ, Yeh ET. Weighing in on heart failure: the role of SERCA2a SUMOylation. Circ Res. 2012 Jan 20; 110(2):198-9.
    View in: PubMed
    Score: 0.017
  20. Calabr? P, Golia E, Yeh ET. Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol. 2012 Jan; 13(1):4-16.
    View in: PubMed
    Score: 0.017
  21. Wang J, Najjar A, Zhang S, Rabinovich B, Willerson JT, Gelovani JG, Yeh ET. Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction. Circ Cardiovasc Imaging. 2012 Jan; 5(1):94-101.
    View in: PubMed
    Score: 0.017
  22. Yeh ET. Microphthalmia-associated transcription factor, melanoma, and renal carcinoma: the small ubiquitin-like modifier connection. Pigment Cell Melanoma Res. 2011 Dec; 24(6):1079-80.
    View in: PubMed
    Score: 0.017
  23. Yeh ET, Lau SC, Su WJ, Tsai DJ, Tu YY, Lai YL. An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan. BMC Cancer. 2011 Sep 06; 11:387.
    View in: PubMed
    Score: 0.016
  24. Dou H, Huang C, Van Nguyen T, Lu LS, Yeh ET. SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett. 2011 Sep 16; 585(18):2891-6.
    View in: PubMed
    Score: 0.016
  25. Yeh ET. Onco-cardiology: the time has come. Tex Heart Inst J. 2011; 38(3):246-7.
    View in: PubMed
    Score: 0.016
  26. Dou H, Huang C, Singh M, Carpenter PB, Yeh ET. Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol Cell. 2010 Aug 13; 39(3):333-45.
    View in: PubMed
    Score: 0.015
  27. Leja MJ, Yeh ET. Cardiovascular risk associated with androgen deprivation therapy. Oncology (Williston Park). 2010 Aug; 24(9):799, 803, 806.
    View in: PubMed
    Score: 0.015
  28. Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM, Yeh ET. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem. 2010 Aug 13; 285(33):25859-66.
    View in: PubMed
    Score: 0.015
  29. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res. 2010 Jun 25; 106(12):1904-11.
    View in: PubMed
    Score: 0.015
  30. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009 Jun 16; 53(24):2231-47.
    View in: PubMed
    Score: 0.014
  31. Calabr? P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009 Jun; 31(1):79-94.
    View in: PubMed
    Score: 0.014
  32. Yeh ET. Adult progenitor cells for cardiac repair: preclinical studies. Tex Heart Inst J. 2009; 36(2):150-1.
    View in: PubMed
    Score: 0.014
  33. Yeh ET. SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem. 2009 Mar 27; 284(13):8223-7.
    View in: PubMed
    Score: 0.013
  34. Daher IN, Yeh ET. Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med. 2008 Dec; 5(12):797-805.
    View in: PubMed
    Score: 0.013
  35. Khakoo AY, Yeh ET. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol. 2008 Nov; 5(11):655-67.
    View in: PubMed
    Score: 0.013
  36. Yusuf SW, Razeghi P, Yeh ET. The diagnosis and management of cardiovascular disease in cancer patients. Curr Probl Cardiol. 2008 Apr; 33(4):163-96.
    View in: PubMed
    Score: 0.013
  37. Yeh E, Ng S, Zhang M, Bouhours M, Wang Y, Wang M, Hung W, Aoyagi K, Melnik-Martinez K, Li M, Liu F, Schafer WR, Zhen M. A putative cation channel, NCA-1, and a novel protein, UNC-80, transmit neuronal activity in C. elegans. PLoS Biol. 2008 Mar 11; 6(3):e55.
    View in: PubMed
    Score: 0.013
  38. Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep. 2008 Feb; 10(1):32-8.
    View in: PubMed
    Score: 0.013
  39. Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem. 2007 Dec 28; 282(52):37341-9.
    View in: PubMed
    Score: 0.012
  40. Zhang S, Shpall E, Willerson JT, Yeh ET. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res. 2007 Mar 16; 100(5):693-702.
    View in: PubMed
    Score: 0.012
  41. Calabro P, Yeh ET. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Subcell Biochem. 2007; 42:63-91.
    View in: PubMed
    Score: 0.012
  42. Gao F, Cheng J, Shi T, Yeh ET. Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFkappaB-dependent transcription. Nat Cell Biol. 2006 Oct; 8(10):1171-7.
    View in: PubMed
    Score: 0.012
  43. Yeh ET, Khan BV. The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis. J Thromb Haemost. 2006 Nov; 4(11):2308-16.
    View in: PubMed
    Score: 0.012
  44. Cheng J, Bawa T, Lee P, Gong L, Yeh ET. Role of desumoylation in the development of prostate cancer. Neoplasia. 2006 Aug; 8(8):667-76.
    View in: PubMed
    Score: 0.011
  45. Gong L, Yeh ET. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem. 2006 Jun 09; 281(23):15869-77.
    View in: PubMed
    Score: 0.011
  46. Yeh ET, Zhang S. A novel approach to studying transformation of human stem cells into cardiac cells in vivo. Can J Cardiol. 2006 Feb; 22 Suppl B:66B-71B.
    View in: PubMed
    Score: 0.011
  47. Yeh ET. Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med. 2006; 57:485-98.
    View in: PubMed
    Score: 0.011
  48. Calabr? P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol. 2005 Nov; 20(6):541-6.
    View in: PubMed
    Score: 0.011
  49. Yeh ET. A new perspective on the biology of C-reactive protein. Circ Res. 2005 Sep 30; 97(7):609-11.
    View in: PubMed
    Score: 0.011
  50. Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005 Sep 20; 46(6):1112-3.
    View in: PubMed
    Score: 0.011
  51. Calabr? P, Samudio I, Safe SH, Willerson JT, Yeh ET. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. J Vasc Res. 2005 Nov-Dec; 42(6):509-16.
    View in: PubMed
    Score: 0.011
  52. Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol. 2005 Sep; 28(9):408-12.
    View in: PubMed
    Score: 0.011
  53. Cheng J, Perkins ND, Yeh ET. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J Biol Chem. 2005 Apr 15; 280(15):14492-8.
    View in: PubMed
    Score: 0.010
  54. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation. 2004 Dec 21; 110(25):3803-7.
    View in: PubMed
    Score: 0.010
  55. Yeh ET. C-reactive protein is an essential aspect of cardiovascular risk factor stratification. Can J Cardiol. 2004 Aug; 20 Suppl B:93B-96B.
    View in: PubMed
    Score: 0.010
  56. Cheng J, Wang D, Wang Z, Yeh ET. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol. 2004 Jul; 24(13):6021-8.
    View in: PubMed
    Score: 0.010
  57. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004 Jun 29; 109(25):3122-31.
    View in: PubMed
    Score: 0.010
  58. Yeh ET. CRP as a mediator of disease. Circulation. 2004 Jun 01; 109(21 Suppl 1):II11-4.
    View in: PubMed
    Score: 0.010
  59. Verma S, Szmitko PE, Yeh ET. C-reactive protein: structure affects function. Circulation. 2004 Apr 27; 109(16):1914-7.
    View in: PubMed
    Score: 0.010
  60. Calabro P, Yeh ET. Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases. Curr Atheroscler Rep. 2004 Jan; 6(1):36-41.
    View in: PubMed
    Score: 0.010
  61. Verma S, Yeh ET. C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol. 2003 Nov; 285(5):R1253-6; discussion R1257-8.
    View in: PubMed
    Score: 0.010
  62. Yeh ET, Zhang S, Wu HD, K?rbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation. 2003 Oct 28; 108(17):2070-3.
    View in: PubMed
    Score: 0.009
  63. Calabr? P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003 Oct 21; 108(16):1930-2.
    View in: PubMed
    Score: 0.009
  64. Gautam N, Mounsey JP, Yeh ETH, Al'Aref SJ. Promises and challenges of machine learning for device therapy in heart failure. Eur Heart J. 2023 05 07; 44(18):1583-1585.
    View in: PubMed
    Score: 0.009
  65. Yeh ET, Palusinski RP. C-reactive protein: the pawn has been promoted to queen. Curr Atheroscler Rep. 2003 Mar; 5(2):101-5.
    View in: PubMed
    Score: 0.009
  66. Wang C, Nistala R, Cao M, Pan Y, Behrens M, Doll D, Hammer RD, Nistala P, Chang HM, Yeh ETH, Kang X. Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells. Cell Rep. 2023 02 28; 42(2):112105.
    View in: PubMed
    Score: 0.009
  67. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003 Jan 28; 107(3):370-1.
    View in: PubMed
    Score: 0.009
  68. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem. 2001 Dec 07; 276(49):46655-60.
    View in: PubMed
    Score: 0.008
  69. Yeh ET, Anderson HV, Pasceri V, Willerson JT. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 2001 Aug 28; 104(9):974-5.
    View in: PubMed
    Score: 0.008
  70. Fujise K, Zhang D, Liu J, Yeh ET. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem. 2000 Dec 15; 275(50):39458-65.
    View in: PubMed
    Score: 0.008
  71. Gong L, Liu M, Jen J, Yeh ET. GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. Biochim Biophys Acta. 2000 Nov 15; 1494(1-2):185-8.
    View in: PubMed
    Score: 0.008
  72. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000 Oct 31; 102(18):2165-8.
    View in: PubMed
    Score: 0.008
  73. Gong L, Kamitani T, Millas S, Yeh ET. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem. 2000 May 12; 275(19):14212-6.
    View in: PubMed
    Score: 0.007
  74. Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene. 2000 May 02; 248(1-2):1-14.
    View in: PubMed
    Score: 0.007
  75. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 2000 Jan 25; 101(3):235-8.
    View in: PubMed
    Score: 0.007
  76. Gong L, Yeh ET. Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem. 1999 Apr 23; 274(17):12036-42.
    View in: PubMed
    Score: 0.007
  77. Gong L, Li B, Millas S, Yeh ET. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett. 1999 Apr 01; 448(1):185-9.
    View in: PubMed
    Score: 0.007
  78. Higuchi M, Honda T, Proske RJ, Yeh ET. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene. 1998 Nov 26; 17(21):2753-60.
    View in: PubMed
    Score: 0.007
  79. Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene. 1998 Nov 12; 17(19):2515-24.
    View in: PubMed
    Score: 0.007
  80. Yeh ET. Life and death of the cell. Hosp Pract (1995). 1998 Aug 15; 33(8):85-7, 91-2.
    View in: PubMed
    Score: 0.007
  81. Kamitani T, Kito K, Nguyen HP, Fukuda-Kamitani T, Yeh ET. Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem. 1998 May 01; 273(18):11349-53.
    View in: PubMed
    Score: 0.006
  82. Gong L, Kamitani T, Fujise K, Caskey LS, Yeh ET. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem. 1997 Nov 07; 272(45):28198-201.
    View in: PubMed
    Score: 0.006
  83. Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997 Nov 07; 272(45):28557-62.
    View in: PubMed
    Score: 0.006
  84. Kamitani T, Nguyen HP, Yeh ET. Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodies. J Biol Chem. 1997 Aug 29; 272(35):22307-14.
    View in: PubMed
    Score: 0.006
  85. Kamitani T, Nguyen HP, Yeh ET. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem. 1997 May 30; 272(22):14001-4.
    View in: PubMed
    Score: 0.006
  86. Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest. 1997 Apr 01; 99(7):1751-8.
    View in: PubMed
    Score: 0.006
  87. Yeh ET. Life and death in the cardiovascular system. Circulation. 1997 Feb 18; 95(4):782-6.
    View in: PubMed
    Score: 0.006
  88. Zhou Z, Wang M, Li J, Xiao M, Chin YE, Cheng J, Yeh ET, Yang J, Yi J. SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer. Oncogene. 2016 11 10; 35(45):5826-5838.
    View in: PubMed
    Score: 0.006
  89. Fadol AP, Banchs J, Hassan SA, Yeh ET, Fellman B. Withdrawal of Heart Failure Medications in Cancer Survivors With Chemotherapy-Induced Left Ventricular Dysfunction: A Pilot Study. J Card Fail. 2016 Jun; 22(6):481-2.
    View in: PubMed
    Score: 0.006
  90. Ferdaoussi M, Dai X, Jensen MV, Wang R, Peterson BS, Huang C, Ilkayeva O, Smith N, Miller N, Hajmrle C, Spigelman AF, Wright RC, Plummer G, Suzuki K, Mackay JP, van de Bunt M, Gloyn AL, Ryan TE, Norquay LD, Brosnan MJ, Trimmer JK, Rolph TP, Kibbey RG, Manning Fox JE, Colmers WF, Shirihai OS, Neufer PD, Yeh ET, Newgard CB, MacDonald PE. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional ? cells. J Clin Invest. 2015 Oct 01; 125(10):3847-60.
    View in: PubMed
    Score: 0.005
  91. Heo KS, Le NT, Cushman HJ, Giancursio CJ, Chang E, Woo CH, Sullivan MA, Taunton J, Yeh ET, Fujiwara K, Abe J. Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest. 2015 Mar 02; 125(3):1299-310.
    View in: PubMed
    Score: 0.005
  92. Cai R, Gu J, Sun H, Liu X, Mei W, Qi Y, Xue S, Ren S, Rabinowitz JE, Wang Y, Yeh ET, Cheng J. Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy. J Mol Cell Cardiol. 2015 Feb; 79:115-22.
    View in: PubMed
    Score: 0.005
  93. Ren YH, Liu KJ, Wang M, Yu YN, Yang K, Chen Q, Yu B, Wang W, Li QW, Wang J, Hou ZY, Fang JY, Yeh ET, Yang J, Yi J. De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells. Oncotarget. 2014 Aug 30; 5(16):7093-104.
    View in: PubMed
    Score: 0.005
  94. Yeh ET, Rosse WF. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J Clin Invest. 1994 Jun; 93(6):2305-10.
    View in: PubMed
    Score: 0.005
  95. Simari RD, Pepine CJ, Traverse JH, Henry TD, Bolli R, Spoon DB, Yeh E, Hare JM, Schulman IH, Anderson RD, Lambert C, Sayre SL, Taylor DA, Ebert RF, Moy? LA. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. Circ Res. 2014 May 09; 114(10):1564-8.
    View in: PubMed
    Score: 0.005
  96. Yeh ET, Kamitani T, Chang HM. Biosynthesis and processing of the glycosylphosphatidylinositol anchor in mammalian cells. Semin Immunol. 1994 Apr; 6(2):73-80.
    View in: PubMed
    Score: 0.005
  97. Yeh ET. Autoimmunity and the pathogenesis of myocarditis. Circulation. 1994 Mar; 89(3):1318-9.
    View in: PubMed
    Score: 0.005
  98. Said R, Banchs J, Wheler J, Hess KR, Falchook G, Fu S, Naing A, Hong D, Piha-Paul S, Ye Y, Yeh E, Wolff RA, Tsimberidou AM. The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials. Ann Oncol. 2014 Jan; 25(1):276-82.
    View in: PubMed
    Score: 0.005
  99. Kamitani T, Chang HM, Rollins C, Waneck GL, Yeh ET. Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk- cells by a human cDNA clone. J Biol Chem. 1993 Oct 05; 268(28):20733-6.
    View in: PubMed
    Score: 0.005
  100. Ky B, Vejpongsa P, Yeh ET, Force T, Moslehi JJ. Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res. 2013 Aug 30; 113(6):754-64.
    View in: PubMed
    Score: 0.005
  101. Heo KS, Chang E, Le NT, Cushman H, Yeh ET, Fujiwara K, Abe J. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Circ Res. 2013 Mar 15; 112(6):911-23.
    View in: PubMed
    Score: 0.005
  102. Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH. Targeting constitutively activated ?1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013 Apr; 11(4):405-17.
    View in: PubMed
    Score: 0.005
  103. Cai R, Yu T, Huang C, Xia X, Liu X, Gu J, Xue S, Yeh ET, Cheng J. SUMO-specific protease 1 regulates mitochondrial biogenesis through PGC-1a. J Biol Chem. 2012 Dec 28; 287(53):44464-70.
    View in: PubMed
    Score: 0.004
  104. Willerson JT, Yeh ET, Perin EC. Cytokine profile and ST-elevation myocardial infarction. Circ Res. 2012 Oct 26; 111(10):1256-7.
    View in: PubMed
    Score: 0.004
  105. Wang Q, Xia N, Li T, Xu Y, Zou Y, Zuo Y, Fan Q, Bawa-Khalfe T, Yeh ET, Cheng J. SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene. 2013 May 09; 32(19):2493-8.
    View in: PubMed
    Score: 0.004
  106. Yeh ET, Chang HM. Pathophysiology and principles of pain management in rheumatic diseases. Curr Opin Rheumatol. 1992 Jun; 4(3):332-6.
    View in: PubMed
    Score: 0.004
  107. Lee MH, Mabb AM, Gill GB, Yeh ET, Miyamoto S. NF-?B induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. Mol Cell. 2011 Jul 22; 43(2):180-91.
    View in: PubMed
    Score: 0.004
  108. Chen CT, Yamaguchi H, Lee HJ, Du Y, Lee HH, Xia W, Yu WH, Hsu JL, Yen CJ, Sun HL, Wang Y, Yeh ET, Hortobagyi GN, Hung MC. Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase. Mol Cancer Ther. 2011 Aug; 10(8):1327-36.
    View in: PubMed
    Score: 0.004
  109. Yan S, Sun X, Xiang B, Cang H, Kang X, Chen Y, Li H, Shi G, Yeh ET, Wang B, Wang X, Yi J. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J. 2010 Nov 17; 29(22):3773-86.
    View in: PubMed
    Score: 0.004
  110. Kang X, Li J, Zou Y, Yi J, Zhang H, Cao M, Yeh ET, Cheng J. PIASy stimulates HIF1a SUMOylation and negatively regulates HIF1a activity in response to hypoxia. Oncogene. 2010 Oct 14; 29(41):5568-78.
    View in: PubMed
    Score: 0.004
  111. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, Shore RE. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):656-65.
    View in: PubMed
    Score: 0.004
  112. Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, Li H, Shi G, Cang H, Sun Y, Wang J, Wang W, Gao F, Yi J. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem. 2010 Apr 23; 285(17):12906-15.
    View in: PubMed
    Score: 0.004
  113. Huang C, Han Y, Wang Y, Sun X, Yan S, Yeh ET, Chen Y, Cang H, Li H, Shi G, Cheng J, Tang X, Yi J. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 2009 Sep 16; 28(18):2748-62.
    View in: PubMed
    Score: 0.004
  114. Willerson JT, Cable G, Yeh ET. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Tex Heart Inst J. 2009; 36(6):530-9.
    View in: PubMed
    Score: 0.003
  115. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, Logothetis CJ, Lin SH. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008 Aug; 6(8):1259-67.
    View in: PubMed
    Score: 0.003
  116. Itahana Y, Yeh ET, Zhang Y. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol. 2006 Jun; 26(12):4675-89.
    View in: PubMed
    Score: 0.003
  117. Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh E, Raad II, Safdar A. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94.
    View in: PubMed
    Score: 0.003
  118. Willerson JT, Yeh ET, Geng YJ, Perin EC. Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. Circ Res. 2005 Oct 14; 97(8):735-6.
    View in: PubMed
    Score: 0.003
  119. Paul A, Yeh ET, Chan L. A proatherogenic role for C-reactive protein in vivo. Curr Opin Lipidol. 2005 Oct; 16(5):512-7.
    View in: PubMed
    Score: 0.003
  120. Owerbach D, McKay EM, Yeh ET, Gabbay KH, Bohren KM. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun. 2005 Nov 18; 337(2):517-20.
    View in: PubMed
    Score: 0.003
  121. Izumiya Y, Ellison TJ, Yeh ET, Jung JU, Luciw PA, Kung HJ. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J Virol. 2005 Aug; 79(15):9912-25.
    View in: PubMed
    Score: 0.003
  122. Veltman IM, Vreede LA, Cheng J, Looijenga LH, Janssen B, Schoenmakers EF, Yeh ET, van Kessel AG. Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25). Hum Mol Genet. 2005 Jul 15; 14(14):1955-63.
    View in: PubMed
    Score: 0.003
  123. Tanaka T, Yeh ET, Kamitani T. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur J Biochem. 2004 Mar; 271(5):972-82.
    View in: PubMed
    Score: 0.002
  124. Tanaka T, Kawashima H, Yeh ET, Kamitani T. Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem. 2003 Aug 29; 278(35):32905-13.
    View in: PubMed
    Score: 0.002
  125. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001 May 29; 103(21):2531-4.
    View in: PubMed
    Score: 0.002
  126. Kito K, Yeh ET, Kamitani T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem. 2001 Jun 08; 276(23):20603-9.
    View in: PubMed
    Score: 0.002
  127. Wada H, Yeh ET, Kamitani T. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J Biol Chem. 2000 Jun 02; 275(22):17008-15.
    View in: PubMed
    Score: 0.002
  128. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, Medrano EE. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res. 2000 Mar 15; 255(2):135-43.
    View in: PubMed
    Score: 0.002
  129. Kito K, Wada H, Yeh ET, Kamitani T. Identification of novel isoforms of human RAD52. Biochim Biophys Acta. 1999 Dec 23; 1489(2-3):303-14.
    View in: PubMed
    Score: 0.002
  130. Wada H, Yeh ET, Kamitani T. The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2. J Biol Chem. 1999 Dec 10; 274(50):36025-9.
    View in: PubMed
    Score: 0.002
  131. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, Maul GG. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 1999 Oct 18; 147(2):221-34.
    View in: PubMed
    Score: 0.002
  132. Wada H, Yeh ET, Kamitani T. Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun. 1999 Apr 02; 257(1):100-5.
    View in: PubMed
    Score: 0.002
  133. Wada H, Kito K, Caskey LS, Yeh ET, Kamitani T. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem Biophys Res Commun. 1998 Oct 29; 251(3):688-92.
    View in: PubMed
    Score: 0.002
  134. Vanderslice P, Ren K, Revelle JK, Kim DC, Scott D, Bjercke RJ, Yeh ET, Beck PJ, Kogan TP. A cyclic hexapeptide is a potent antagonist of alpha 4 integrins. J Immunol. 1997 Feb 15; 158(4):1710-8.
    View in: PubMed
    Score: 0.001
  135. Ware RE, Howard TA, Kamitani T, Chang H-M, Yeh ETH, Seldin MF. Chromosomal assignment of genes involved in glycosylphosphatidylinositol anchor biosynthesis: implications for the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood. 1994 06 15; 83(12):3753-7.
    View in: PubMed
    Score: 0.001
  136. Norris J, Hall S, Ware RE, Kamitani T, Chang HM, Yeh E, Rosse WF. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. Blood. 1994 Feb 01; 83(3):816-21.
    View in: PubMed
    Score: 0.001
  137. Kodukula K, Amthauer R, Cines D, Yeh ET, Brink L, Thomas LJ, Udenfriend S. Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins. Proc Natl Acad Sci U S A. 1992 Jun 01; 89(11):4982-5.
    View in: PubMed
    Score: 0.001
  138. Zietman AL, Sugiyama E, Ramsay JR, Silobrcic V, Yeh ET, Sedlacek RS, Suit HD. A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies. Int J Cancer. 1991 Mar 12; 47(5):755-9.
    View in: PubMed
    Score: 0.001
  139. Reiser H, Oettgen H, Yeh ET, Terhorst C, Low MG, Benacerraf B, Rock KL. Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell. 1986 Nov 07; 47(3):365-70.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.